anonymous
Guest
anonymous
Guest
Hope it is one of my competitors. I don’t work there anymore. It would be great to see my competitors destroyed and demoralized.
We aren’t going to be interested in Amgen
much of their play is in Biosimilars which Novartis isn’t interested in as if they were, they would have kept parts of Sandoz
I don’t see BMS, could see GSK with the consumer business unit being sold off to pay for part of the deal
Vas has to be careful
He pissed $10B down the drain with the Medicine company deal
Merger with BMS?
Merger with BMS?